Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Isidro Cortés‐Ciriano, Jake June-Koo Lee, Ruibin Xi, Dhawal Jain, Youngsook L. Jung, Lixing Yang, Dmitry A. Gordenin, Leszek J. Klimczak, Cheng‐Zhong Zhang, David Pellman, Peter J. Park, on behalf of the Pcawg Structural Variation Working Group, the Icgc/tcga Pan-Cancer Analysis of Whole Genomes NetworkbioRxiv 2018 · DOI

TL;DR

Chromothripsis, a massive genomic rearrangement event, is far more common in human cancers than previously thought, affecting a significant portion of tumors across many cancer types. This study provides a comprehensive analysis of chromothripsis using whole-genome sequencing data, revealing its diverse mechanisms and its role in driving cancer evolution.

What Problem Does This Paper Address?

Cancer development is often viewed as a gradual accumulation of mutations. However, some cancers exhibit massive, catastrophic genomic rearrangements occurring in a single event, a phenomenon known as chromothripsis. Previous estimates of chromothripsis prevalence were based on lower-resolution data and suggested it was relatively rare. This paper aims to provide a more accurate and comprehensive understanding of chromothripsis by analyzing a large dataset of whole-genome sequencing data from thousands of human tumors, investigating its frequency, characteristics, underlying mechanisms, and impact on cancer.

Methods

The researchers developed a computational tool called ShatterSeek to detect chromothripsis events from whole-genome sequencing (WGS) data. This method identifies clusters of structural variations (SVs) with overlapping breakpoints and analyzes copy number (CN) profiles for characteristic oscillations between two or three states. They also incorporated criteria to detect events involving multiple chromosomes and considered signatures of different DNA repair mechanisms. The study utilized a stringent quality control pipeline for WGS data and applied statistical thresholds and visual inspection to refine chromothripsis calls, distinguishing between "high-confidence" and "low-confidence" events.

Datasets

The study analyzed whole-genome sequencing data from 2,658 tumor and matched normal pairs spanning 39 cancer types. These data were integrated from the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) consortia.

Key Insights and Ideas

  • Chromothripsis is pervasive: This catastrophic genomic event is not a rare anomaly but a major driver of genome evolution in a significant proportion of human cancers.
  • Beyond canonical patterns: While classic chromothripsis involves oscillations between two copy number states, this study reveals a substantial fraction of events involve multiple chromosomes and more complex structural alterations.
  • Diverse mechanisms at play: Beyond non-homologous end-joining (NHEJ), the study found evidence of replicative processes and templated insertions contributing to chromothripsis.
  • Impact on cancer drivers: Chromothripsis contributes to the amplification of oncogenes and the inactivation of tumor suppressor genes, including those involved in DNA repair.
  • Prognostic significance: Chromothripsis is associated with poorer patient survival, particularly in diploid tumors.

Key Results

  • High-confidence chromothripsis events were identified in 27% of the analyzed samples (690 out of 2,543), affecting 2.4% of all chromosomes. When low-confidence calls were included, the prevalence rose to 38.3% of samples.
  • Frequencies varied significantly across cancer types, with 100% of liposarcomas and 77% of osteosarcomas showing high-confidence chromothripsis. Several other cancer types, including ovarian, breast, and lung adenocarcinomas, also showed high prevalence (>50%).
  • Chromothripsis events frequently involved multiple chromosomes (affecting only a single chromosome in 40.2% of cases).
  • The study found that 30% of tumors with chromothripsis showed clustered APOBEC-induced mutations, and 10% displayed kataegis.
  • Patients with inactivating TP53 mutations had a 1.54-fold increased odds ratio for chromothripsis compared to TP53 wild-type cases.
  • Chromothripsis was associated with significantly worse survival in a stratified analysis, particularly in diploid tumors.

Limitations and Future Work

  • Sensitivity of detection: The authors acknowledge that the estimated frequencies depend on the cut-off values used for statistical significance and that some chromothripsis-like patterns might have arisen from other sources of genomic instability. It's also possible that small-scale events with fewer rearrangements were missed.
  • Complexity of detection: Cases where chromothripsis is followed by other complex rearrangements that mask the canonical CN pattern are difficult to detect and may require further refinement of criteria and manual inspection.
  • Distinguishing processes: While the study provides evidence for various repair mechanisms and replicative processes, further experiments are needed to fully assess their interplay in chromothripsis.
  • Therapeutic potential: The authors suggest that understanding the link between chromothripsis, aneuploidy, immune infiltration, and treatment response could lead to its use as a biomarker for diagnosis or treatment. Further research linking WGS data with clinical information is needed to explore this potential.

Summary updated

Abstract

Summary Chromothripsis is a newly discovered mutational phenomenon involving massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies in cancer suggest that chromothripsis may be far more common than initially inferred from low resolution DNA copy number data. Here, we analyze the patterns of chromothripsis across 2,658 tumors spanning 39 cancer types using whole-genome sequencing data. We find that chromothripsis events are pervasive across cancers, with a frequency of >50% in several cancer types. Whereas canonical chromothripsis profiles display oscillations between two copy number states, a considerable fraction of the events involves multiple chromosomes as well as additional structural alterations. In addition to non-homologous end-joining, we detect signatures of replicative processes and templated insertions. Chromothripsis contributes to oncogene amplification as well as to inactivation of genes such as mismatch-repair related genes. These findings show that chromothripsis is a major process driving genome evolution in human cancer.
BibTeX
@misc{cortesciriano2018comprehensive,
  author = {Isidro Cortés‐Ciriano and Jake June-Koo Lee and Ruibin Xi and Dhawal Jain and Youngsook L. Jung and Lixing Yang and Dmitry A. Gordenin and Leszek J. Klimczak and Cheng‐Zhong Zhang and David Pellman and Peter J. Park and on behalf of the PCAWG Structural Variation Working Group and the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Network},
  title = {{Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing}},
  year = {2018},
  doi = {10.1101/333617},
  howpublished = {bioRxiv},
}

Loading related content...

Figure